Searched for
DCGI OFFICIAL
Drug regulator transfers 95 officials in mass reshuffleThe Central Drugs Standard Control Organisation has moved about 95 officials across India. This reshuffle aims to improve compliance and le...- Centre waives testing requirement for SII's Cy-Tb injection at govt labs: SourcesThe DCGI had approved market authorisation of Cy-Tb injection on May 9, 2022, but even after a year of approval, Cy-Tb is not available in ...
- Govt panel recommends permission for phase 3 trial of Sputnik Light vaccine as booster doseHyderabad-based Dr. Reddy's Laboratories had presented its proposal to DCGI for conducting the phase-3 trial of Sputnik Light vaccine as bo...
- DTAB recommends granting licence to manufacture, stock new drugs, jabs under clinical trialBased on the recommendation, the Drugs Controller General of India (DCGI) has sent a draft proposal to the Union Health Ministry for approv...
- DCGI seeks more data from SII over its application seeking emergency authorisation for CovovaxSerum Institute of India (SII) had sent an application to the DCGI in October for the grant of market authorisation of Covovax for restrict...
- Serum Institute gets DCGI's nod to manufacture Sputnik V in India for test, analysis"The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test and anal...
- Roche Diagnostics India first private firm to get COVID-19 test approvalSwiss firm Roche Diagnostics India received the license for conducting coronavirus tests after approval from drug regulator DCGI, making it...
- Govt seeks complaints on ‘dissolving stents’, but has no system to act on itThe Indian Pharmacopoeia Commission in Ghaziabad is the national coordination centre for the materio vigilance programme.
- Novartis may be fined for submitting ‘fake’ document to Drug Controller General of IndiaNovartis may face penalties in India for submitting 'fake' document to the Drug Controller General of India (DCGI) for a veterinary medicin...
- DCGI asks Novartis to explain 'violations' in papers on drug manufactureDCGI has sought an explanation for the "violation" in 10 days, apart from asking for detailed documentation for all imported products.
- DCGI asks Wockhardt to explain lapses at its plantDrug regulator has sent a letter to Wockhardt, an official said, adding that the deficiencies found by its inspection team did not warrant ...
- No decision on Ranbaxy probe yet: Health MinistryThe Health min is still taking stock of the Ranbaxy Labs' US-related problems, but has not yet decided to launch any probe on the matter
- Torrent Pharma recalls acidity drug after failing quality testTorrent Pharma has become the first of the large pharmaceuticals firm to withdraw a drug under a new recall and alert system kicked off by ...
- Pharmaceutical companies including Cipla deny charges of collusion with drug regulator in drug trialsSeveral drug manufacturers accused of colluding with the sector regulator and medical experts to allegedly violate approval norms have deni...
- Drug Regulator office has gone defunct as a quasi regulatory body takes charge of crucial approvalsDrug companies say that due to this committee, the DCGI has become non accountable to issues of drug approvals.
- Natco Pharma faces criminal actionThe country’s top drug regulator plans to initiate criminal proceedings against Hyderabad-based Natco Pharma for selling “substandard” brea...
- Pharma cos will require DCGI nod for exportsDomestic pharmaceutical companies will not be able to export medicines without the approval of central drug regulator Drug Controller Gener...
- Government to crack whip on errant drug companiesThe government will soon amend its drug laws to give the health ministry explicit powers to punish companies that unethically test drugs un...
- Bitter pill for evading price control normsDrug companies trying to fleece consumers—knocking off price-controlled active ingredients from their popular brands, but retaining the bra...
- New fake drug definition to boost credibility of local medical sectorThe Drug Controller General of India (DCGI) is planning to adopt a new definition of counterfeit drugs.
Load More
